Takashi Kei Kishimoto
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 29, 2023
Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents.Petr O Ilyinskii, Christopher Roy, Alicia Michaud
|Apr 04, 2022
Addressing high dose AAV toxicity - 'one and done' or 'slower and lower'?Takashi Kei Kishimoto, Richard Jude Samulski
|Jan 13, 2022
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia.Earl Sands, Alan Kivitz, Wesley DeHaan
|Feb 25, 2021
Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles.Petr O Ilyinskii, Alicia M Michaud, Christopher J Roy
Pageof 1
